Centenary Institute

Award Ceremony: 2020 Centenary Institute Medical Innovation Awards

(Date indicative of previous years. Check website for further information)

The Centenary Institute’s Medical Innovation Awards recognise some of Australia’s inspirational young post-doctoral scientists and provided a catalyst for them to gain wider recognition for their research projects, particularly in the funding arena.

The 1st place $30,000 In Memory of Neil Lawrence Prize, sponsored by
Commonwealth Private, will be presented to the biomedical research scientist based in Australia who demonstrates the most creative and innovative approach to their research concept.

The researcher positioned in 2nd place will receive the Bayer Innovation Award of $15,000.The Harvard Club of Australia Foundation will provide a $5,000 Travel Prize to one of the finalists to undertake a study tour to Harvard University in Boston, USA.

The People’s Choice Award will enable the Australian public to engage with the Awards, having the opportunity to vote in the $2,000 People’s Choice Award.

Nominations close 5 July 2019

People’s choice voting closes 5 August 2019

Award ceremony will be held on 21 August 2019 in Sydney

For more, visit: https://www.centenary.org.au/cimia/ 

Nominations Close: 2019 Centenary Institute Medical Innovation Awards

The Centenary Institute’s Medical Innovation Awards recognise some of Australia’s inspirational young post-doctoral scientists and provided a catalyst for them to gain wider recognition for their research projects, particularly in the funding arena.

The 1st place $30,000 In Memory of Neil Lawrence Prize, sponsored by
Commonwealth Private, will be presented to the biomedical research scientist based in Australia who demonstrates the most creative and innovative approach to their research concept.

The researcher positioned in 2nd place will receive the Bayer Innovation Award of $15,000.The Harvard Club of Australia Foundation will provide a $5,000 Travel Prize to one of the finalists to undertake a study tour to Harvard University in Boston, USA.

The People’s Choice Award will enable the Australian public to engage with the Awards, having the opportunity to vote in the $2,000 People’s Choice Award.

Nominations close 5 July 2019

People’s choice voting closes 5 August 2019

Award ceremony will be held on 21 August 2019 in Sydney

For more, visit: https://www.centenary.org.au/cimia/ 

Nominations Open: 2019 Centenary Institute Medical Innovation Awards

The Centenary Institute’s Medical Innovation Awards recognise some of Australia’s inspirational young post-doctoral scientists and provided a catalyst for them to gain wider recognition for their research projects, particularly in the funding arena.

The 1st place $30,000 In Memory of Neil Lawrence Prize, sponsored by
Commonwealth Private, will be presented to the biomedical research scientist based in Australia who demonstrates the most creative and innovative approach to their research concept.

The researcher positioned in 2nd place will receive the Bayer Innovation Award of $15,000.The Harvard Club of Australia Foundation will provide a $5,000 Travel Prize to one of the finalists to undertake a study tour to Harvard University in Boston, USA.

The People’s Choice Award will enable the Australian public to engage with the Awards, having the opportunity to vote in the $2,000 People’s Choice Award.

Nominations close 5 July 2019

People’s choice voting closes 5 August 2019

Award ceremony will be held on 21 August 2019 in Sydney

For more, visit: https://www.centenary.org.au/cimia/ 

Indonesian and Australian scientists test new TB vaccine targets for the TB fight in Indonesia and Australia

World TB Day on March 24 reminds us of the growing TB threat

Scientists available for interview in English and Bahasa Indonesia for World TB Day. Read the release in Bahasa Indonesia.
More images below.

Better vaccines are needed for the global fight against tuberculosis (TB). The Global Fund reports an estimated nine million new cases globally per year of TB, which is second only to AIDS as the world’s most deadly infectious disease. Indonesia had more than 320,000 reported cases in 2014 according to the World Health Organization, while Australia’s reported cases were just over 1,000. But the rise of drug-resistant TB poses a threat to all countries.

Two proteins from the tuberculosis bacterium have shown promising results in investigations in mice for a new vaccine. Scientists from the Centenary Institute and the University of Sydney, with colleagues at Universitas Gadjah Mada (UGM) in Yogyakarta, have found that the injected proteins can prime the immune system to induce protection against TB in mice.

The team has established a laboratory and immunological techniques to test if the two proteins from the tuberculosis bacterium can be used as the basis for a vaccine. Credit: Centenary Institute

The team has established a laboratory and immunological techniques to test if the two proteins from the tuberculosis bacterium can be used as the basis for a vaccine. Credit: Centenary Institute

[continue reading…]

Using diet to cope with the aftermath of stroke

Connie Wong 1_LR$25,000 Centenary Institute Lawrence Creative Prize goes to young Melbourne researcher

One of Australia’s most creative young medical researchers has won a $25,000 prize to help her develop her ideas on how diet could prevent stroke deaths.

Connie Wong thinks we may be able to prevent early deaths following stroke with a fibre-based diet. She initially used innovative microscope techniques to determine how stroke weakens the immune system. Now she is studying how it also induces leakiness in the gut wall, leading to infection and an upsurge in deaths. And the solution may well lie in diet.

[continue reading…]

Keeping our best young bioscience brains in Australia

Centenary Institute Lawrence Creative Prize to be announced, finalists from Melbourne and Sydney

The winner of the Centenary Institute Lawrence Creative Prize will be announced at 6.30 pm, Tuesday 12 November 2013, at a reception hosted by UBS in Sydney.

There are three finalists. On Tuesday we will find out who is the overall winner of the $25,000 prize. The two runners-up will each receive $5,000.

[continue reading…]

Simple cough could save lives from TB

A community-wide screening program being trialled in Vietnam aims to create a new model for global TB control

In the 1950s and 1960s Australians were accustomed to having regular chest x-rays in a caravan, parked in their suburb, to screen for TB. During this time TB almost (but not quite) disappeared from Australia and the program was phased out.

Now Australian researchers from the Centenary Institute, Woolcock Institute of Medical Research and the Centre of Research Excellence on TB Control will assess the potential for a similar program of regular community-wide screening to have the same impact on TB in Vietnam, a country in which TB is still very common and costs many lives. However, instead of x-rays the team will use a new molecular test that is performed on sputum coughed up from patient’s lungs to detect TB. They hope their work will serve as a model for countries with a high burden of TB in our region and elsewhere.

[continue reading…]

Keeping our best young bioscience brains in Australia: Centenary Institute Lawrence Creative Prize

The winner of the Centenary Institute Lawrence Creative Prize will be announced at 12.30 pm, Thursday 15 November 2012, at a lunch at UBS in Sydney.

He will receive $25,000, and a glass trophy designed by Australian sculptor Nick Mount.

The 2012 finalists are:

  • Robert McLaughlin, a medical engineer from the University of Western Australia (UWA), who has developed an optical probe that fits inside a hypodermic needle and can help surgeons accurately determine the boundaries of breast cancer tumours.
  • Marc Pellegrini, from Melbourne’s Walter and Eliza Hall Institute (WEHI), whose discoveries about how the body regulates its immune system are being applied to clinical trials of cancer vaccines and treatments for HIV and hepatitis.
  • Jian Yang, from the Diamantina Institute at the University of Queensland, who has solved a major puzzle of missing heritability by developing software and methods to determine the multiple genes involved in conditions such as schizophrenia, obesity and diabetes.